ZyVersa Therapeutics, Inc. (ZVSA) reported Loss for second quarter of -$2.211 million
The company's bottom line came in at -$2.211 million, or -$0.46 per share. This compares with -$2.763 million, or -$3.31 per share, last year.
ZyVersa Therapeutics, Inc. earnings at a glance (GAAP) :
-Earnings: -$2.211 Mln. vs. -$2.763 Mln. last year.-EPS: -$0.46 vs. -$3.31 last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.